Modig Berndt 4

What Happened
Berndt Modig, CEO of Pharvaris N.V., sold a total of 23,333 shares of Pharvaris common stock in open-market transactions on April 9, 2026 (transaction code S). The sales consisted of 23,133 shares reported at a weighted average price of $27.74 for proceeds of $641,598, and 200 shares reported at $28.41 for proceeds of $5,683 — total proceeds approximately $647,281. The filing indicates these sales were made pursuant to a Rule 10b5-1 trading plan and include shares acquired upon vesting of restricted stock units.

Key Details

• Transaction date: 2026-04-09 (filed 2026-04-10) — filing appears timely.
• Reported sales:
  • 23,133 shares at a weighted-average price $27.74 (proceeds $641,598). Footnote: actual sale prices ranged $27.31–$28.30.
  • 200 shares at $28.41 (proceeds $5,683). Footnote: actual sale prices ranged $28.32–$28.51.
• Total shares sold: 23,333; total proceeds: ~$647,281.
• Shares included shares from vested restricted stock units. Sales were made under a Rule 10b5-1 plan (prearranged trading plan).
• Reporting entity note: Schoodif Management BV is an entity controlled by Mr. Modig (per footnote).
• Shares owned after transaction: not specified in the provided filing excerpt.
• Filing timeliness: not marked late; filed the day after the transaction.

Context
Sales under a Rule 10b5-1 plan are preplanned and are often routine liquidity events (the Form 4 discloses the plan and RSU origin but does not indicate motive). Code S indicates these were outright sales of shares rather than option exercises, awards, or gifts. For investors, purchases can be a stronger signal of insider confidence; this filing documents a sale and should be viewed as a disclosure of insider activity rather than a direct statement about company prospects.